Home > Research > Publications & Outputs > Lactate Protects Microglia and Neurons from Oxy...

Electronic data

Links

Text available via DOI:

View graph of relations

Lactate Protects Microglia and Neurons from Oxygen-Glucose Deprivation/Reoxygenation

Research output: Contribution to Journal/MagazineJournal articlepeer-review

E-pub ahead of print

Standard

Lactate Protects Microglia and Neurons from Oxygen-Glucose Deprivation/Reoxygenation. / Tassinari, Isadora D'Ávila; Rodrigues, Fernanda da Silva; Bertram, Craig et al.
In: Neurochemical research, Vol. 49, 31.07.2024, p. 1762-1781.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Tassinari IDÁ, Rodrigues FDS, Bertram C, Mendes-da-Cruz DA, Guedes RP, Paz AH et al. Lactate Protects Microglia and Neurons from Oxygen-Glucose Deprivation/Reoxygenation. Neurochemical research. 2024 Jul 31;49:1762-1781. Epub 2024 Mar 29. doi: 10.1007/s11064-024-04135-7

Author

Bibtex

@article{5d95bfb2b78b4a889acf604d3f204937,
title = "Lactate Protects Microglia and Neurons from Oxygen-Glucose Deprivation/Reoxygenation",
abstract = "Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation. ",
keywords = "Oxygen and glucose deprivation, Neuron, Lactate, Microglia, Metabolism",
author = "Tassinari, {Isadora D'{\'A}vila} and Rodrigues, {Fernanda da Silva} and Craig Bertram and Mendes-da-Cruz, {Daniella Ar{\^e}as} and Guedes, {Renata Padilha} and Paz, {Ana Helena} and Victorio Bambini-Junior and {de Fraga}, {Luciano St{\"u}rmer}",
year = "2024",
month = mar,
day = "29",
doi = "10.1007/s11064-024-04135-7",
language = "English",
volume = "49",
pages = "1762--1781",
journal = "Neurochemical research",
issn = "1573-6903",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Lactate Protects Microglia and Neurons from Oxygen-Glucose Deprivation/Reoxygenation

AU - Tassinari, Isadora D'Ávila

AU - Rodrigues, Fernanda da Silva

AU - Bertram, Craig

AU - Mendes-da-Cruz, Daniella Arêas

AU - Guedes, Renata Padilha

AU - Paz, Ana Helena

AU - Bambini-Junior, Victorio

AU - de Fraga, Luciano Stürmer

PY - 2024/3/29

Y1 - 2024/3/29

N2 - Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation.

AB - Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation.

KW - Oxygen and glucose deprivation

KW - Neuron

KW - Lactate

KW - Microglia

KW - Metabolism

U2 - 10.1007/s11064-024-04135-7

DO - 10.1007/s11064-024-04135-7

M3 - Journal article

C2 - 38551797

VL - 49

SP - 1762

EP - 1781

JO - Neurochemical research

JF - Neurochemical research

SN - 1573-6903

ER -